Corona vaccine for children, Bharat Biotech approves trial on 2 to 18 years old (TKB-Health)

India is currently facing the second wave of Corona virus, along with this the work of vaccination is also going on. Experts have expressed the apprehension that if the third wave of corona comes, it can have a great impact on the children as well. Now a big step has been taken in this episode.

The Subject Expert Committee (SEC) on the Corona Vaccine on Tuesday recommended Bharat Biotech’s trial of covacine on children between 2 and 18 years of age, which has been approved.

This clinical trial will be done on 525 people, it will be in MIMS hospitals of Delhi AIIMS, Patna AIIMS, Nagpur. According to the recommendations of the committee, Bharat Biotech will have to provide complete data of Phase 2 before starting the Phase 3 trial.

The SEC recommended that India should approve biotech clinical trials of Phase 2, Phase 3 of Covaxine, which would be done on children between 2 and 18 years.

Let us tell you that only two vaccines being used in India are being vaccinated only to those above 18 years of age. Covishield of Serum Institute in India, Bharat Biotech Covaxin is being applied to the people.

Experts warned about the third wave …
The second wave of Corona in India has caused havoc. Meanwhile, experts warned of a third wave. The Chief Scientific Advisor of the Government of India had said that the coming of the third wave is certain and it may have a greater impact on children.

After the advice of experts, the Supreme Court also expressed concern about the third wave from the central government. The Supreme Court had questioned that if the third wave comes, what will happen to the children, what will happen to their families, how will they be treated, these things need to be considered from now.

After warning of the third wave, many states have already started working on building a separate hospital for children, special covid care centers.